Activated mesangial cells produce vascular permeability factor in early- stage mesangial proliferative glomerulonephritis

Journal of the American Society of Nephrology

Volumn 9, Issue 10, 1998, Pages 1815-1825

  Noguchi, Kukiko ^a   Yoshikawa, Norishige ^a   Ito Kariya, Seiko ^a   Inoue, Yuji ^a   Hayashi, Yoshitake ^a   Ito, Hiroshi ^a   Nakamura, Hajime ^a   Iijima, Kazumoto ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; ENZYME ACTIVATION; HEMOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MESANGIUM CELL; PODOCYTE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN LOCALIZATION; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

EID: 0031685281     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983
2. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989
3. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50: 1774-1778, 1990
4. Connolly DT, Olander JV, Heuvelman DM, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J: Human vascular permeability factor: Isolation from U937 cells. J Biol Chem 264: 20017-20024, 1989
5. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991
6. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172: 1535-1545, 1990
7. Plouët J, Moukadiri H: Specific binding of vasculotropin to bovine brain capillary endothelial cells. Biochemie 72: 51-55, 1990
8. Plouët J, Moukadiri H: Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem 265: 22071-22074, 1990
9. Vaisman N, Gospodarowicz D, Neufeld G: Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265: 19461-19466, 1990
10. Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, Kao J: Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81: 2767-2773, 1993
11. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992
12. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586, 1992
13. Brown LF, Berse B, Tognazzi K, Manseau EJ, van de Water L, Senger DR, Dvorak HF, Rosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42: 1457-1461, 1992
14. Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264: C995-C1002, 1993
15. Simon M, Gröne HJ, Jöhren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268: F240-F250, 1995
16. Uchida K, Uchida S, Nitta K, Yumura W, Marumo F, Nihei H: Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. Am J Physiol 266: F81-F88, 1994
17. Iijima K, Yoshikawa N, Connolly DT, Nakamura H: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44: 959-966, 1993
18. Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88: 6560-6564, 1991
19. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86: 453-462, 1990
20. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346: 371-374, 1990
21. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68: 154-163, 1993
22. Niemir ZI, Stein H, Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48: 1530-1541, 1995
23. Churg J: Focal glomerulonephritis, diffuse mesangial proliferative glomerulonephritis, diffuse endocapillary proliferative glomerulonephritis. In: Renal Disease: Classification and Atlas of Glomerular Disease, 2nd Ed., edited by Churg J, Bernstein J, Glassock RJ, Tokyo, Igaku-shoin, 1995, pp 85-105
24. Yoshikawa N, Iijima K, Maehara K, Yoshiara S, Yoshiya K, Matsuo T, Okada S: Mesangial changes in IgA nephropathy in children. Kidney Int 32: 585-589, 1987
25. Jackson MR, Carney EW, Lye SJ, Ritchie JW: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15: 341-353, 1994
26. Dawson-Saunders B, Trapp RG: Comparing three or more means. In: Basic and Clinical Biostatistics, Norwalk, Appleton & Lange, 1990, pp 124-141
27. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7: 661-666, 1996
28. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87: 847-858, 1991
29. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992
30. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter AR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo TK: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53: 2912-2918, 1993
31. Berse B, Brown LF, van de Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3: 211-220, 1992
32. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrum M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 55: 4140-4145, 1995
33. Iijima K, Yoshikawa N, Nakamura H: Activation-induced production of vascular permeability factor in human peripheral T cells: A nonradioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. J Immunol Methods 196: 199-209, 1996
34. Iruela-Arispe L, Gordon K, Hugo C, Duijvestjn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147: 1715-1727, 1995
35. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906, 1991
36. Uemori EN, Ferrara N, Bauer EA, Amneto EP: Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153: 557-562, 1992
37. Asahara T, Bauters C, Pasture CJ, Kearney M, Rossow S, Bulting S, Ferrara N, Symes JF, Isner JM: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91: 2793-2801, 1995
38. 165 gene transfer. Circulation 94: 3291-3302, 1996
39. Isner JM, Walsh K, Rosenfield K, Schainfeld R, Asahara T, Hogan K, Pieczek A: Arterial gene therapy for restenosis. Hum Gene Ther 7: 989-1011, 1996
40. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC: Macrophages in renal injury. Kidney Int 45: S79-S82, 1994
41. Takahashi T, Shirasawa T, Miyake K, Yahagi Y, Maruyama N, Kasahara N, Kawamura T, Matsumura O, Mitarai T, Sakai O: Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun 209: 218-226, 1995
42. Klanke B, Gröne HJ, Gros H, Simon M, Stolte H, Weich HA: Effects of vascular endothelial growth factor (VEGF) on hemodynamics and permselectivity of the isolated perfused rat kidney (IPRK) [Abstract]. J Am Soc Nephrol 5: 582, 1994